LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/The Shutdown and Orthopedics
Legal & Regulatory and Reimbursement

The Shutdown and Orthopedics

October 1, 2013 2 min read Premium comments

Advertisement

The Shutdown and Orthopedics
Image created by RRY Publications, LLC / Source: Wikimedia
Secondary

What does the government shutdown mean for the orthopedic community?

Not much for now. The shutdown won’t impact Medicare, Medicaid, Social Security or any of the essential government services required to protect the borders, public health and other mandatory functions, including Obamacare.

During the 1995–1996 government shutdown, Medicare continued to pay physicians and hospitals according to prevailing payment rates, since claims are made out of the Medicare trust funds and not current appropriations.

While a government shutdown for any period of time could result in delays in claims processing, audits, and other administrative functions, most essential functions of Medicare, Medicaid, and ACA (Affordable Care Act) implementation will continue to operate under emergency and mandatory funding.

Regulatory Consequences

But there may be regulatory consequences.

According to a statement posted on September 27, 2013 by the U.S. Department of Health and Human Services (HHS), FDA “would continue limited activities related to its user fee funded programs.” The statement said out of a total of 14, 779 FDA employees, 6, 620 would be furloughed, leaving 8, 180 (55%) retained.

FDA would have the staff in place to “continue select vital activities including maintaining critical consumer protection to handle emergencies, high-risk recalls, civil and criminal investigations, import entry review, and other critical public health issues…Carryover funding from user fees paid by industry” might also support FDA in a shutdown, continued the statement.

Advertisement

However, HHS said “routine establishment inspections, ” some “compliance and enforcement activities, ” the “majority” of its laboratory research testing, and the “majority” of its food safety and nutrition testing would not be carried out.

What about regulations and guidance documents ordinarily released by FDA on a regular basis?

The Federal Register Office said that in the event of a government shutdown, it would only publish “documents directly related to the performance of governmental functions necessary to address imminent threats to the safety of human life or protection of property.” FDA would be charged with making this determination for its own documents.

Most of its non-essential staff will be out of the office, so it seems unlikely that the FDA would be publishing regulatory or guidance documents.

Here is where we stand now. The House passed a bill to defund Obamacare. The Senate rejected it, the House then passed another version that would have abolished the devices tax and delay Obamacare for a year. When the Senate rejected that, the House passed another bill that would have delayed the individual mandate and revoked health insurance subsidies for congressional staffers. After the Senate said no to that, the clock ran out and the government shut down. The House has now asked for private negotiations in a conference committee. The Senate said no.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy